Luvo Health NAD+ review

The breadth is useful when the format stays visible

Luvo Health gives NAD a place in its longevity program and distinguishes injection, drops and nasal spray. Its pricing page lists the broader longevity category at $145–$199 per four weeks, alongside sermorelin and B12/MIC options. ^[1] That makes Luvo relevant to a format comparison while preventing a single simple NAD price conclusion.

I would consider it for someone who wants to discuss the format with a clinician rather than arrive committed to one route. The menu creates flexibility, but also makes precision important. The cheapest category figure should not be assumed to buy the injection, a particular quantity, or every other product listed nearby.

Choose the actual preparation before calculating value

The dedicated injection page and the pricing menu identify distinct NAD routes. ^{[1] [2]} A quote should name which one is prescribed, its concentration or strength, the supplied quantity and the administration instructions. Without those particulars, a four-week price can look comparable while describing different treatment.

This is especially relevant if the appeal is avoiding injections or avoiding an infusion appointment. Convenience preferences deserve a place in the decision, with realistic expectations about what research transfers between preparations. A different route is not a cosmetic change to the same evidence package. Ask the prescriber to explain the proposed choice rather than decide that the most direct-sounding route must be the most effective.

Read our NAD delivery-format guide for the next part of the decision.

Four weeks and a calendar month are different budgets

Luvo publishes a four-week interval and plan lengths ranging from four to 24 weeks for the longevity category. It says the selected price covers clinician consultation and reviews, medication, shipping and support. ^[1] That bundled description is useful if the written quote confirms the same scope for the individual order.

Use the stated interval in a comparison instead of silently treating it as a calendar month. Ask whether a longer plan is paid upfront and what renewal creates after the initial commitment. A lower equivalent rate can be attractive without being the easiest payment obligation. Value depends on the actual total and flexibility, especially when the personal benefit of an optional treatment remains uncertain.

The clinical explanation should not end at NAD biology

Luvo markets the injection within longevity care. ^[2] That placement does not demonstrate that the program extends lifespan or reliably resolves fatigue. The small human intravenous NAD pilot investigated metabolism around one infusion, rather than testing this service or its home preparation on those outcomes. ^[4]

I would ask the clinician to name a realistic treatment purpose and explain what evidence applies to the selected route. That is more useful than a broad statement about cellular energy. A normal biological role does not establish that giving additional material improves a particular person’s symptoms. The benefit discussion should be just as specific as the label and bill, with room to decide that another assessment or approach is more appropriate.

Read our human infusion evidence review for the next part of the decision.

Cancellation has two separate boundaries

Luvo’s policy asks for at least 72 hours’ notice before the next billing date. It also defines medication as ordered once the prescription is transmitted to a dispensing pharmacy. Clinical services are nonrefundable once rendered, and current-cycle refunds depend on whether medication has been ordered. ^[3]

This means stopping future renewal and obtaining a current-cycle refund are different questions. Save the selected billing date and ask how the policy applies to a multiweek plan. A cancellation request made before delivery can still come after the relevant pharmacy event. I regard the published boundary as useful disclosure, while the reader needs to understand its practical effect before choosing a longer package.

The best fit is a reader comfortable with a defined plan

Luvo also says bundled-plan refund calculations use the standard non-bundled rate for shipments already received. ^[3] That can change the financial result of ending a discounted plan early. Compare the arrangement on the assumption that the selected terms actually apply, rather than imagining every unused week is refunded at the promotional equivalent.

My verdict is that Luvo’s bundled-care structure and visible format choices are worth considering, once the quote identifies the exact NAD product. I would not choose it purely from the $145 category minimum. The stronger decision combines a clear clinical purpose, acceptable uncertainty, an understandable four-week budget and a cancellation arrangement that still feels reasonable if the reader decides not to continue.

Read our CoreAge versus AgelessRx comparison for the next part of the decision.

Understanding the cost

The longevity category lists $145–$199 per four weeks. This range does not price every NAD+ route; confirm the selected preparation, first charge, renewal and supply period. ^[1]